WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 2.8% of their position (5K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $4.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/22/2024ACC: 0001213900-24-101610
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+5K
Net shares
Net buyer
$4.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.50K
Price / share
$0.95
Trade value
$2.38K
% of position
1.4%
11/20/2024
180.43K→182.93K
Common Stock
Direct
Shares
+2.50K
Price / share
$0.90
Trade value
$2.25K
% of position
1.4%
11/22/2024
182.93K→185.43K
Total
Net shares
+5K
Net value
$4.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2024 | P · Purchase | +2.50K | $0.95 | $2.38K | 1.4% | 180.43K | 182.93K |
| Common Stock Direct | 11/22/2024 | P · Purchase | +2.50K | $0.90 | $2.25K | 1.4% | 182.93K | 185.43K |
| Total | +5K | $4.63K | ||||||
Derivative Transactions0
No derivative transactions reported